Applied Therapeutics Stock Price on November 6, 2024
| APLT Stock | USD 8.57 1.64 16.06% |
Below is the normalized historical share price chart for Applied Therapeutics extending back to May 14, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Applied Therapeutics stands at 8.57, as last reported on the 27th of November, with the highest price reaching 10.40 and the lowest price hitting 8.39 during the day.
If you're considering investing in Applied Stock, it is important to understand the factors that can impact its price. Applied Therapeutics is risky given 3 months investment horizon. Applied Therapeutics secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. We were able to break down and interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.13% are justified by taking the suggested risk. Use Applied Therapeutics Downside Deviation of 4.3, mean deviation of 3.88, and Risk Adjusted Performance of 0.1035 to evaluate company specific risk that cannot be diversified away.
At this time, Applied Therapeutics' Common Stock Total Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 88.5 M in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 955.9 K in 2024. . Price To Sales Ratio is likely to drop to 22.59 in 2024. Price Earnings Ratio is likely to drop to -2.47 in 2024. Applied Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of May 2019 | 200 Day MA 6.1333 | 50 Day MA 8.6834 | Beta 2.018 |
Applied |
Sharpe Ratio = 0.1215
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | APLT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.32 actual daily | 82 82% of assets are less volatile |
Expected Return
| 1.13 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Applied Therapeutics is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Applied Therapeutics by adding it to a well-diversified portfolio.
Price Book 201.6293 | Enterprise Value Ebitda (9.71) | Price Sales 54.676 | Shares Float 84.8 M | Wall Street Target Price 14.6667 |
Related Headline
Mineralys Therapeutics, Headline on 6th of November 2024
Disposition of 25482 shares by Rodman David Malcom of Minera... by MacroaxisInsider
Filed transaction by Mineralys Therapeutics, Common Officer: Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Applied Therapeutics Valuation on November 6, 2024
It is possible to determine the worth of Applied Therapeutics on a given historical date. On November 6, 2024 Applied was worth 9.93 at the beginning of the trading date compared to the closed value of 9.65. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Applied Therapeutics stock. Still, in general, we apply an absolute valuation method to find Applied Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Applied Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Applied Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 9.32 | 9.86 | 9.00 | 9.63 | 2,194,583 | |
11/06/2024 | 9.93 | 9.98 | 9.50 | 9.65 | 2,027,757 |
| 9.65 | 9.92 | 9.43 | 9.74 | 1,282,883 |
| Backtest Applied Therapeutics | | | Applied Therapeutics History | | | Applied Therapeutics Valuation | Previous | Next |
Applied Therapeutics Trading Date Momentum on November 6, 2024
| On November 07 2024 Applied Therapeutics was traded for 9.74 at the closing time. The top price for the day was 9.92 and the lowest listed price was 9.43 . The trading volume for the day was 1.3 M. The trading history from November 7, 2024 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 0.93% . The overall trading delta against the current closing price is 10.05% . |
Applied Therapeutics Fundamentals Correlations and Trends
By evaluating Applied Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Applied Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Applied financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Applied Therapeutics Stock history
Applied Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Applied is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Applied Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Applied Therapeutics stock prices may prove useful in developing a viable investing in Applied Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 84.2 M | 88.5 M | |
| Net Loss | -95 M | -90.3 M |
Applied Therapeutics Stock Technical Analysis
Applied Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Applied Therapeutics Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Applied Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Applied Therapeutics November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Applied Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Applied Therapeutics shares will generate the highest return on investment. By undertsting and applying Applied Therapeutics stock market strength indicators, traders can identify Applied Therapeutics entry and exit signals to maximize returns
Applied Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Applied Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Applied Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Applied to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1035 | |||
| Jensen Alpha | 1.1 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.2338 | |||
| Treynor Ratio | 5.52 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.